|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash Flows From Operating Activities | |||||
| Net income | |||||
| Adjustments to reconcile net income to net cash provided by operating activities: | |||||
| Depreciation and amortization | |||||
| Deferred compensation | |||||
| Realized and unrealized (gains) on long-term investments | |||||
| Stock-based compensation | |||||
| Deferred income taxes | |||||
| Goodwill impairment (Note 4) | |||||
| Goodwill and other intangibles impairment (Note 4) | |||||
| Other non-cash items | |||||
| Changes in assets and liabilities, excluding effects of acquisitions: | |||||
| Receivables, net | |||||
| Inventories | |||||
| Other current assets | |||||
| Accounts payable and accrued liabilities | |||||
| Pension liabilities | |||||
| Environmental and legal liabilities | |||||
| Deferred revenues | |||||
| Net Cash Provided By Operating Activities | |||||
| Cash Flows From Investing Activities | |||||
| Expenditures for property, plant and equipment | |||||
| Proceeds from sales of assets (Note 20) | |||||
| Other, net | |||||
| Net Cash Used In Investing Activities | |||||
| Cash Flows From Financing Activities | |||||
| Revolving debt and bank overdrafts, net (Note 6) | |||||
| Other debt borrowings (Note 6) | |||||
| Other debt repayments (Note 6) | |||||
| Dividends paid | |||||
| Stock option exercises | |||||
| Other, net | |||||
| Net Cash Provided By (Used In) Financing Activities | |||||
| Effect of Exchange Rate Changes on Cash | |||||
| Net Increase (Decrease) in Cash and Cash Equivalents | |||||
| Cash and Cash Equivalents at Beginning of Year | |||||
| Cash and Cash Equivalents at End of Year | |||||
| Supplemental Cash Flow Information | |||||
| Cash payments of income taxes, net of refunds (Note 9) | |||||
| Cash payments of interest | |||||
Loading...
